Literature DB >> 31002055

Mixed Mycobacterium tuberculosis Lineage Infection in 2 Elephants, Nepal.

Sarad Paudel, Chie Nakajima, Susan K Mikota, Kamal P Gairhe, Bhagwan Maharjan, Suraj Subedi, Ajay Poudel, Mariko Sashika, Michito Shimozuru, Yasuhiko Suzuki, Toshio Tsubota.   

Abstract

Tuberculosis in elephants is primarily caused by Mycobacterium tuberculosis. We identified mixed M. tuberculosis lineage infection in 2 captive elephants in Nepal by using spoligotyping and large sequence polymorphism. One elephant was infected with Indo-Oceanic and East African-Indian (CAS-Delhi) lineages; the other was infected with Indo-Oceanic and East Asian (Beijing) lineages.

Entities:  

Keywords:  Mycobacterium tuberculosis; Nepal; TB; bacteria; elephants; lineage; tuberculosis; tuberculosis and other mycobacteria; zoonoses

Mesh:

Year:  2019        PMID: 31002055      PMCID: PMC6478232          DOI: 10.3201/eid2505.181898

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Mycobacterium tuberculosis is a primary cause of tuberculosis (TB) in elephants (). Culture of trunk wash samples is regarded as the standard method for the diagnosis of TB in elephants; however, this method has many limitations (). We previously reported TB in 3 elephants in Nepal that was caused by M. tuberculosis of Indo-Oceanic lineage (). Here, we report on mixed M. tuberculosis lineage infection in 2 captive elephants from Chitwan National Park (CNP) in Nepal. Elephant A was a female elephant ≈65–70 years old. She had been in retirement for 3 years before she died in February 2013. We observed TB-like lesions in the lungs postmortem (Appendix Figure 1). Elephant B was a 32-year-old male. His body condition had substantially deteriorated for several months before he died. We found extensive TB-like lesions in the lungs at postmortem. We performed the DPP VetTB Assay (Chembio Inc., http://chembio.com), a serologic test, on the postmortem lung fluid (an off-label use) of elephant A and the serum of elephant B; results were reactive in both cases, indicating the presence of antibodies to TB. We processed the suspected lung lesions according to standard guidelines () and performed culture by using Löwenstein–Jensen media. We performed genetic analyses on the 2 M. tuberculosis isolates by using spoligotyping and large-sequence polymorphism (LSP) as described previously (). We amplified the direct-repeat region with a primer pair and hybridized the PCR products to a set of 43 oligonucleotide probes corresponding to each spacer covalently bound to the membrane. We identified the spoligo-international type by comparing spoligotypes with the international spoligotyping database (SpolDB4) (). We performed LSP on the isolates by using specific primers for respective lineages, as described previously (). We identified the elephant isolates as a mixture of 2 strains based on uneven spoligotyping color development (suggesting mixture) and LSP detection PCR results (2 bands were observed). The spoligotyping results showed that the elephant A isolate had a new spoligotype that was not found in the international spoligotyping database. The elephant B isolate belonged to the Indo-Oceanic lineage (East African–Indian 5 spoligo-international type 1365) (Table). The prevalence of the Indo-Oceanic lineage among human TB patients in Nepal is only 11.5% (). The drug resistance–associated region sequences rpoB, katG, inhA promoter region, and gyrA were all wild types in both isolates. Similarly, LSP results showed that elephant A was infected by the Indo-Oceanic and East African–Indian lineages (CAS-Delhi) (Appendix Figure 2), whereas elephant B was infected with the East Asian type (Beijing type) (Appendix Figure 3). The prevalence of CAS-Delhi and Beijing type lineages in Nepal in human TB patients is 40.6% and 32.2%, respectively (). In the gyrA sequence, both of the samples showed a mixed peak of T231C, suggesting that the East African–Indian type is a Nepal-specific lineage.
Table

Genotypic characteristics of Mycobacterium tuberculosis isolates from 2 elephants, Nepal*

SourceSpoligotype† binary code SITCladegyrA
Elephant A1110000111111111111111001111000010111111111New§New§T231C
Elephant B00000000000000000000000011110000101111111111365EAI5T231C

*EAI5, East African–Indian 5; SIT, spoligo-international type.
†Spoligotype was determined as previously described by Brudey et al. (6). 
‡Mutation in a partial sequence of gyrA. The gyrA sequence of both elephant isolates had a synonymous single nucleotide polymorphism from T to C at position 231.
§Not found in the international spoligotyping database (SpolDB4).

*EAI5, East African–Indian 5; SIT, spoligo-international type.
†Spoligotype was determined as previously described by Brudey et al. (6). 
‡Mutation in a partial sequence of gyrA. The gyrA sequence of both elephant isolates had a synonymous single nucleotide polymorphism from T to C at position 231.
§Not found in the international spoligotyping database (SpolDB4). Our study shows that the first elephant was infected with the Indo-Oceanic and East African–Indian (CAS-Delhi) M. tuberculosis lineages, whereas the second elephant was infected with the Indo-Oceanic and East Asian (Beijing) lineages. We previously identified the Indo-Oceanic lineage in 3 elephants from Nepal (). We suspect that this lineage might be well adapted in elephants in Nepal. We diagnosed the mixed lineage infection postmortem in both elephants. However, a successful antemortem diagnosis of mixed infection in a single elephant would enable a precise TB diagnosis and selection of an appropriate anti-TB treatment, which could eventually lead to the control of this disease at the herd level. The source of these mixed infections is unknown and could be from humans or elephants infected with these lineages. Infected elephant handlers who have daily close contact would be a likely human source. Genotyping of additional isolates from elephants and their handlers will help to determine the source of infection. We recommend regular TB screening of elephant handlers to safeguard human health and help prevent transmission of TB from humans to elephants.

Appendix

Additional information regarding mixed Mycobacterium tuberculosis lineage infection in 2 elephants, Nepal.
  6 in total

1.  Molecular characterization of Mycobacterium tuberculosis isolates from elephants of Nepal.

Authors:  Sarad Paudel; Susan K Mikota; Chie Nakajima; Kamal P Gairhe; Bhagwan Maharjan; Jeewan Thapa; Ajay Poudel; Michito Shimozuru; Yasuhiko Suzuki; Toshio Tsubota
Journal:  Tuberculosis (Edinb)       Date:  2014-01-08       Impact factor: 3.131

2.  Tuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatment.

Authors:  Konstantin P Lyashchenko; Rena Greenwald; Javan Esfandiari; John H Olsen; Ray Ball; Genevieve Dumonceaux; Freeland Dunker; Carol Buckley; Michael Richard; Suzan Murray; Janet B Payeur; Peter Andersen; John M Pollock; Susan Mikota; Michele Miller; Denise Sofranko; W Ray Waters
Journal:  Clin Vaccine Immunol       Date:  2006-07

3.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Variable host-pathogen compatibility in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Kathryn DeRiemer; Tran Van; Midori Kato-Maeda; Bouke C de Jong; Sujatha Narayanan; Mark Nicol; Stefan Niemann; Kristin Kremer; M Cristina Gutierrez; Markus Hilty; Philip C Hopewell; Peter M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

5.  First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Nepal.

Authors:  Bijaya Malla; David Stucki; Sonia Borrell; Julia Feldmann; Bhagwan Maharjan; Bhawana Shrestha; Lukas Fenner; Sebastien Gagneux
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

6.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.

Authors:  Karine Brudey; Jeffrey R Driscoll; Leen Rigouts; Wolfgang M Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patricia Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Dario Garcia de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison M Gomes; M Cristina Guttierez; Peter M Hawkey; Paul D van Helden; Gurujaj V Kadival; Barry N Kreiswirth; Kristin Kremer; Milan Kubin; Savita P Kulkarni; Benjamin Liens; Troels Lillebaek; Minh Ly Ho; Carlos Martin; Christian Martin; Igor Mokrousov; Olga Narvskaïa; Yun Fong Ngeow; Ludmilla Naumann; Stefan Niemann; Ida Parwati; Zeaur Rahim; Voahangy Rasolofo-Razanamparany; Tiana Rasolonavalona; M Lucia Rossetti; Sabine Rüsch-Gerdes; Anna Sajduda; Sofia Samper; Igor G Shemyakin; Urvashi B Singh; Akos Somoskovi; Robin A Skuce; Dick van Soolingen; Elisabeth M Streicher; Philip N Suffys; Enrico Tortoli; Tatjana Tracevska; Véronique Vincent; Tommie C Victor; Robin M Warren; Sook Fan Yap; Khadiza Zaman; Françoise Portaels; Nalin Rastogi; Christophe Sola
Journal:  BMC Microbiol       Date:  2006-03-06       Impact factor: 3.605

  6 in total
  1 in total

1.  Insights into transmission dynamics of Mycobacterium tuberculosis complex in Nepal.

Authors:  Yogendra Shah; Sarad Paudel; Kishor Pandey; Govind Prasad Gupta; Eddie Samuneti Solo; Jagadish Joshi; Dhan Kumar Pant; Basu Dev Pandey
Journal:  Trop Med Health       Date:  2022-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.